Compare Ginkgo Bioworks Holdings Inc (DNA) vs National Beverage Corp. (FIZZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs National Beverage Corp. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while National Beverage Corp. trades at $30.52 (market cap $2.89B). The key difference: National Beverage Corp. is far larger — about 3.8× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, National Beverage Corp. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and National Beverage Corp. for 33 Days on average.
| DNA | FIZZ | |
|---|---|---|
Market Cap | $763.64M | $2.89B |
Volume | 3,204,177 | 553,950 |
Sector | Health | Consumer Staples |
52-Week High | $15.83 | $37.73 |
52-Week Low | $5.48 | $29.20 |
Typical Hold Time | 7 Days | 33 Days |
Enterprise Value | $865.59M | $2.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.
DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.
National Beverage Corp. (FIZZ) trades at $30.52, up 3.11% today, showing mixed signals with a bullish technical outlook but bearish analyst sentiment. The company reported flat revenue of $1.2B in 2025 with net income of $186.82M, while recent quarterly earnings have missed expectations. Technical indicators show support at $30 and resistance at $31, with RSI in neutral territory. Recent news highlights margin pressure from tariffs and a $3.25 special dividend payment.
FIZZ faces headwinds from stalled revenue growth and margin compression, though strong profitability metrics (40.13% ROE) provide some support. Analyst consensus is cautious with 50% sell ratings, while institutional activity shows mixed positioning. The stock's valuation appears reasonable at 16.58 P/E, but investors should monitor earnings recovery and competitive pressures in the beverage sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →
